ESPR
Esperion Therapeutics Inc
Price:  
2.44 
USD
Volume:  
3,227,596.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ESPR EV/EBITDA

-560.0%
Upside

As of 2024-03-05, the EV/EBITDA ratio of Esperion Therapeutics Inc (ESPR) is -3.79. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ESPR's latest enterprise value is 583.99 mil USD. ESPR's TTM EBITDA according to its financial statements is -154.25 mil USD. Dividing these 2 quantities gives us the above ESPR EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.7x - 13.2x 12.0x
Forward P/E multiples 6.7x - 15.3x 12.2x
Fair Price (9.98) - (12.20) (11.22)
Upside -509.2% - -600.2% -560.0%
2.44 USD
Stock Price
(11.22) USD
Fair Price

ESPR EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-03-04 -3.79
2024-03-01 -3.91
2024-02-29 -3.87
2024-02-28 -3.94
2024-02-27 -4.32
2024-02-26 -4.01
2024-02-23 -3.98
2024-02-22 -4.01
2024-02-21 -3.98
2024-02-20 -4.07
2024-02-16 -4.08
2024-02-15 -4.04
2024-02-14 -3.98
2024-02-13 -3.90
2024-02-12 -3.97
2024-02-09 -3.95
2024-02-08 -3.95
2024-02-07 -4.01
2024-02-06 -3.95
2024-02-05 -3.72
2024-02-02 -3.50
2024-02-01 -3.36
2024-01-31 -3.44
2024-01-30 -3.30
2024-01-29 -3.47
2024-01-26 -3.43
2024-01-25 -3.37
2024-01-24 -3.31
2024-01-23 -3.43
2024-01-22 -3.45
2024-01-19 -3.30
2024-01-18 -3.45
2024-01-17 -3.94
2024-01-16 -4.22
2024-01-12 -4.46
2024-01-11 -4.44
2024-01-10 -4.15
2024-01-09 -4.19
2024-01-08 -4.20
2024-01-05 -3.91
2024-01-04 -3.63
2024-01-03 -3.62
2024-01-02 -4.34
2023-12-29 -4.43
2023-12-28 -4.53
2023-12-27 -4.24
2023-12-26 -3.95
2023-12-22 -3.69
2023-12-21 -3.66
2023-12-20 -3.59